← 返回

肿瘤微环境:有效癌症治疗的屏障还是机遇

英文原题:Tumor microenvironment: barrier or opportunity towards effective cancer therapy.

查看英文原题

Tumor microenvironment: barrier or opportunity towards effective cancer therapy.

PubMed 2022/10/17(内容时间) J Biomed Sci Q1 · IF 14.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤微环境(TME)是宿主组分构成的一种特化生态系统,由肿瘤细胞设计以促进肿瘤的成功发展和转移。随着3D培养和先进生物信息学方法的出现,如今已有可能在更高分辨率下研究TME的各个组分及其相互作用。对TME中免疫细胞多样性、基质成分、免疫组库分析、新抗原预测的深入理解,为探索免疫治疗干预的空间和时间调控提供了机会。患者之间TME组成的差异在决定癌症免疫治疗的应答者和无应答者方面发挥着重要作用。因此,可能存在着重编程TME组分以克服广泛存在的免疫治疗耐药问题的可能性。本综述的重点是理解TME的复杂性,并认识其组分作为潜在治疗靶点的未来前景。综述的后半部分描述了新兴的复杂3D模型作为研究TME组分的宝贵手段,并详细介绍了用于分析TME组分和预测新抗原的先进生物信息学工具。总体而言,本综述全面阐述了目前可用于靶向TME的知识。

展开英文摘要原文

Tumor microenvironment (TME) is a specialized ecosystem of host components, designed by tumor cells for successful development and metastasis of tumor. With the advent of 3D culture and advanced bioinformatic methodologies, it is now possible to study TME's individual components and their interplay at higher resolution.

Deeper understanding of the immune cell's diversity, stromal constituents, repertoire profiling, neoantigen prediction of TMEs has provided the opportunity to explore the spatial and temporal regulation of immune therapeutic interventions. The variation of TME composition among patients plays an important role in determining responders and non-responders towards cancer immunotherapy.

Therefore, there could be a possibility of reprogramming of TME components to overcome the widely prevailing issue of immunotherapeutic resistance. The focus of the present review is to understand the complexity of TME and comprehending future perspective of its components as potential therapeutic targets. The later part of the review describes the sophisticated 3D models emerging as valuable means to study TME components and an extensive account of advanced bioinformatic tools to profile TME components and predict neoantigens.

Overall, this review provides a comprehensive account of the current knowledge available to target TME.

论文信息

作者
Tiwari A、Trivedi R、Lin SY
第一作者单位
Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. atiwari3@mdanderson.org.United States
通讯作者单位
Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sylin@mdanderson.org.United States
文献类型
综述
期刊
Journal of biomedical science2022 Oct 17
原文标识
PubMed 36253762 · DOI 10.1186/s12929-022-00866-3